导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -29.19% | 1041/1050 |
| 近一周 | -3.74% | 1053/1104 |
| 近一月 | -14.74% | 1094/1103 |
| 近一季 | -20.64% | 948/1094 |
| 近半年 | -34.99% | 1069/1074 |
| 近一年 | -31.83% | 1007/1020 |
| 近两年 | 12.91% | 826/926 |
| 近三年 | -28.25% | 804/834 |
| 成立以来 | 234.06% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.73% 539/1070 |
-13.19% 978/1101 |
- - |
- - |
| 2025 | 23.78% 603/1065 |
2.42% 612/1014 |
-3.77% 922/1038 |
34.64% 279/1050 |
-6.72% 784/1065 |
| 2024 | -10.35% 772/1011 |
-12.40% 834/960 |
-9.98% 867/983 |
21.91% 43/991 |
-6.75% 767/1011 |
| 2023 | -26.80% 787/952 |
2.28% 493/880 |
-7.93% 692/895 |
-16.20% 805/915 |
-7.24% 700/952 |
| 2022 | -24.50% 477/867 |
-15.78% 296/773 |
16.11% 95/806 |
-20.21% 760/845 |
-3.23% 588/867 |
| 2021 | 42.15% 34/740 |
-6.68% 406/580 |
25.60% 79/659 |
17.20% 24/704 |
3.47% 279/740 |
| 2020 | 134.41% 1/554 |
-7.99% 357/419 |
50.01% 6/466 |
12.09% 200/517 |
51.52% 2/554 |
| 2019 | 45.87% 178/410 |
26.92% 554/1149 |
-15.48% 1150/1231 |
11.20% 95/390 |
22.29% 8/410 |
| 2018 | -39.11% 276/349 |
- - |
- - |
- - |
-13.09% 744/1080 |
| 2017 | -3.87% 186/285 |
- - |
- - |
- - |
- - |
| 2016 | -23.92% 133/205 |
- - |
- - |
- - |
- - |
| 2015 | 58.35% 15/151 |
- - |
- - |
- - |
- - |
| 2014 | 9.52% 19/24 |
- - |
- - |
- - |
- - |
| 2013 | 41.42% 2/21 |
- - |
- - |
- - |
- - |
| 2012 | -0.62% 135/157 |
- - |
- - |
- - |
- - |
| 2011 | -24.09% 69/102 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 汇丰晋信低碳先锋股票A VS. 东吴新产业精选股票A(580008) |